Admetsys Develops Artificial Pancreas for Critical Care
May 17, 2018 @ 19:06

Admetsys, a company headquartered in Boston, has developed a system for controlling blood glucose levels in critical care patients.Essentially an artificial pancreas, the system relies on a lab-on-a-chip that’s embedded within an intravenous catheter to measure glucose and lactic acid, automatically…

Sourced through from:

Leave a Reply